Transpek Inds.

Why is Transpek Industry Ltd falling/rising?

As of 30-Jul, Transpek Industry Ltd's stock price is rising to 1,094.50, reflecting a 5.08% increase. This rise is due to strong relative performance, a trend reversal after declines, and current prices above several moving averages, despite longer-term challenges.

As of 30-Jul, Transpek Industry Ltd's stock price is rising, currently at 1,094.50, reflecting a change of 52.9 (5.08%) upward. This increase can be attributed to several factors. Notably, the stock has outperformed its sector by 8.74% today, indicating strong relative performance. Additionally, there has been a trend reversal as the stock gained after two consecutive days of decline, suggesting a potential shift in investor sentiment.<BR><BR>The stock also reached an intraday high of Rs 1,125, marking an increase of 8.01% during the trading session. Despite a decrease in delivery volume by 37.44% against the 5-day average, the stock remains liquid enough for trading, which may contribute to its price stability. Furthermore, the stock's current price is higher than its 5-day, 20-day, 50-day, and 100-day moving averages, although it is lower than the 200-day moving average. This positioning may indicate a short-term bullish trend despite longer-term challenges, as evidenced by its year-to-date decline of 13.68% and a significant drop of 35.61% over the past year. Overall, the combination of today's positive performance metrics and the recent trend reversal appears to be driving the stock's rise.

Which are the latest news on Transpek Inds.?

When is the next results date for Transpek Industry Ltd?

The next results date for Transpek Industry Ltd is August 7, 2026.

The next results date for Transpek Industry Ltd is scheduled for August 7, 2026.

How big is Transpek Inds.?

As of 10th June, Transpek Industry Ltd has a market capitalization of 559.00 Cr, with recent net sales of 621.20 Cr and a net profit of 45.65 Cr. Shareholder's funds are 745.32 Cr, and total assets amount to 1,000.54 Cr.

As of 10th June, Transpek Industry Ltd has a market capitalization of 559.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest 4 quarters, the company reported Net Sales of 621.20 Cr and a Net Profit of 45.65 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 745.32 Cr and Total Assets of 1,000.54 Cr.

Who are in the management team of Transpek Inds.?

The management team of Transpek Industries includes A C Shroff (Chairman), A G Shroff, Bimal V Mehta (Managing Director), D K Shroff, Ravi A Shroff, and several independent directors, totaling a diverse group that combines executive and independent perspectives.

The management team of Transpek Industries includes the following individuals:<BR><BR>1. A C Shroff - Chairman & Non-Executive Director<BR>2. A G Shroff - Non-Executive Director<BR>3. Bimal V Mehta - Executive Director / Managing Director / Non-Promoter<BR>4. D K Shroff - Non-Executive Director<BR>5. Ravi A Shroff - Non-Executive Director<BR>6. Bernd Dill - Independent Non-Executive Director<BR>7. Ninad D Gupte - Independent Non-Executive Director<BR>8. Nimishbhai U Patel - Independent Non-Executive Director<BR>9. Geeta Goradia - Independent Non-Executive Director<BR>10. Hemantkumar J Bhatt - Independent Non-Executive Director<BR>11. A M Tiwari - Independent Non-Executive Director<BR>12. Avtar Singh - Joint Managing Director<BR><BR>This diverse team brings a mix of executive and independent perspectives to the company's governance.

Who are the peers of the Transpek Inds.?

Transpek Inds. peers include Tuticorin Alkali, OCCL, Chemfab Alka, Vikram Thermo, Primo Chemicals, POCL Enterprises, Andhra Petrochem, Lords Chloro, Kanoria Chem, and Mangalam Organic. OCCL shows the best management and growth metrics, while Transpek Inds. has a 1-year return of -43.11%.

Peers: The peers of Transpek Inds. are Tuticorin Alkali, OCCL, Chemfab Alka., Vikram Thermo, Primo Chemicals, POCL Enterprises, Andhra Petrochem, Lords Chloro, Kanoria Chem., and Mangalam Organic.<BR><BR>Quality Snapshot: Excellent management risk is observed at OCCL, while Average management risk is found at Tuticorin Alkali, Chemfab Alka., Vikram Thermo, Primo Chemicals, Transpek Inds., POCL Enterprises, Andhra Petrochem, Lords Chloro, and Mangalam Organic, and Below Average management risk is noted at Kanoria Chem. and the rest. Growth is Excellent at OCCL and POCL Enterprises, Good at Tuticorin Alkali and Lords Chloro, while Below Average growth is seen at Chemfab Alka., Vikram Thermo, Primo Chemicals, Transpek Inds., Andhra Petrochem, and Mangalam Organic, with the rest showing Average growth. Capital Structure is Excellent at OCCL, Chemfab Alka., Vikram Thermo, and Andhra Petrochem, Good at Transpek Inds., Average at Primo Chemicals and Lords Chloro, and Below Average at POCL Enterprises and Kanoria Chem.<BR><BR>Return Snapshot: The peer with the highest 1-year return is OCCL at 8.60%, while the lowest is Chemfab Alka. at -50.09%. Transpek Inds. has a 1-year return of -43.11%, which is higher than Chemfab Alka. but lower than OCCL. Additionally, the six-month return is negative for Chemfab Alka., Transpek Inds., POCL Enterprises, Andhra Petrochem, Lords Chloro, and Mangalam Organic.

What does Transpek Inds. do?

Transpek Industry Limited is a global supplier of chlorinated products, primarily serving the pharmaceuticals, agrochemicals, and dyes sectors. As of March 2026, it reported net sales of 148 Cr and a net profit of 7 Cr, with a market cap of INR 559 Cr.

Overview:<BR>Transpek Industry Limited is a leading global supplier of chlorinated products in the commodity chemicals industry, focusing on sectors such as pharmaceuticals, agrochemicals, and dyes.<BR><BR>History:<BR>Transpek Industry Limited was incorporated in an unspecified year and has maintained its status as a micro-cap company. The latest quarterly results reported net sales and net profit for the period ending March 2026.<BR><BR>Financial Snapshot:<BR>- Net Sales: 148 Cr (Quarterly Results - Mar 2026)<BR>- Net Profit: 7 Cr (Quarterly Results - Mar 2026)<BR>- Market-cap: INR 559 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 12.00<BR>- Industry P/E: 42<BR>- Dividend Yield: 2.05%<BR>- Debt Equity: -0.07<BR>- Return on Equity: 5.95%<BR>- Price to Book: 0.71<BR><BR>Contact Details:<BR>Address: 4th Floor, Gotri Sevasi Road Vadodara Gujarat : 390021<BR>Tel: 91-265-2335444/2335446/2335447/141<BR>Email: secretarial@transpek.com<BR>Website: http://www.transpek.com

Should I buy, sell or hold Transpek Industry Ltd?

Are Transpek Industry Ltd latest results good or bad?

Transpek Industry Ltd's latest Q4 FY26 results are concerning, showing a 65.82% year-on-year decline in net profit and a significant drop in operating margins to 11.96%. Overall, the company faces challenges in profitability and operational efficiency, indicating a negative outlook for investors.

Transpek Industry Ltd's latest results for Q4 FY26 indicate a troubling performance. The company reported a net profit of ₹6.58 crores, which represents a significant decline of 65.82% year-on-year and 39.35% quarter-on-quarter. Additionally, net sales fell to ₹148.22 crores, marking a 10.31% decrease year-on-year and a 6.47% decline from the previous quarter. <BR><BR>The operating margin has also contracted sharply, dropping to 11.96%, down from 19.50% in the same quarter last year. This decline in margins reflects ongoing operational challenges and pressures on profitability. The company's reliance on other income has raised concerns about the sustainability of its earnings, as nearly half of its profit before tax came from non-operating sources.<BR><BR>Overall, these results suggest that Transpek Industry is facing significant difficulties in maintaining its operational efficiency and profitability, leading to a negative outlook for the company. Investors should be cautious given the consistent decline in key financial metrics and the lack of visible catalysts for recovery.

Is Transpek Inds. technically bullish or bearish?

As of November 19, 2025, Transpek Inds. has a bearish technical trend with moderate strength, indicated by bearish daily moving averages and Bollinger Bands, while the MACD and KST show mixed signals, contributing to its underperformance compared to the Sensex.

As of 19 November 2025, the technical trend for Transpek Inds. has changed from mildly bearish to bearish. The current technical stance is bearish with moderate strength. Key indicators driving this stance include the bearish signals from the daily moving averages and the Bollinger Bands on both weekly and monthly time frames. The MACD shows a mildly bullish signal on the weekly but is bearish on the monthly, indicating a lack of consistent momentum. Additionally, the KST is mildly bullish on the weekly but bearish on the monthly, further supporting the bearish outlook. Overall, the stock has underperformed significantly compared to the Sensex across multiple time frames, reinforcing the bearish sentiment.

Is Transpek Inds. overvalued or undervalued?

As of November 17, 2025, Transpek Industries is fairly valued with a PE ratio of 13.02, making it an attractive investment compared to its peers, despite a year-to-date return of -13.69%.

As of 17 November 2025, the valuation grade for Transpek Industries has moved from expensive to fair. The company is currently fairly valued, with a PE ratio of 13.02, a Price to Book Value of 0.99, and an EV to EBITDA of 6.53. These ratios indicate a reasonable valuation compared to its peers in the commodity chemicals sector.<BR><BR>In comparison to its peers, Transpek's valuation appears attractive, especially when contrasted with Solar Industries, which has a PE ratio of 95.31, and Gujarat Fluoroch, with a PE of 57.85, both classified as very expensive. Additionally, Aarti Industries, another peer, has a fair valuation with a PE of 53.15. Despite recent stock performance lagging behind the Sensex, with a year-to-date return of -13.69% compared to the Sensex's 8.72%, the current valuation metrics suggest that Transpek Industries offers a compelling investment opportunity within its sector.

How has been the historical performance of Transpek Inds.?

Transpek Inds. experienced fluctuating financial performance, with net sales increasing to 649.85 Cr in March 2025 but declining from 826.90 Cr in March 2023. Despite revenue challenges, the company showed resilience with improved operating profit, profit before tax, and cash flow from operating activities.

Answer:<BR>The historical performance of Transpek Inds. shows a fluctuating trend in key financial metrics over the years.<BR><BR>Breakdown:<BR>Transpek Inds. reported net sales of 649.85 Cr in March 2025, an increase from 579.63 Cr in March 2024, but a decline from 826.90 Cr in March 2023. The total operating income followed a similar pattern, reaching 649.85 Cr in March 2025 compared to 579.63 Cr in the previous year. The raw material cost rose to 330.33 Cr in March 2025 from 293.86 Cr in March 2024, contributing to a total expenditure of 555.17 Cr, up from 497.32 Cr in March 2024. Operating profit (PBDIT) increased to 123.39 Cr in March 2025 from 107.47 Cr in March 2024, while profit before tax also rose to 61.66 Cr from 55.51 Cr. However, profit after tax saw a more modest increase to 48.74 Cr from 38.56 Cr. The earnings per share (EPS) improved to 87.19 in March 2025 from 68.98 in March 2024. On the balance sheet, total assets grew to 1,000.54 Cr in March 2025 from 965.67 Cr in March 2024, and total liabilities also increased to 1,000.54 Cr from 965.67 Cr. Cash flow from operating activities rose to 135.00 Cr in March 2025 from 97.00 Cr in March 2024, indicating improved cash generation capabilities. Overall, while Transpek Inds. faced some challenges in revenue, it demonstrated resilience in profitability and asset growth.

Who are the top shareholders of the Transpek Inds.?

The top shareholders of Transpek Industries include Anshul Specialty Molecules Private Limited with 24.64%, individual investors holding 31.39%, and Mukul Mahavir Agrawal as the largest public shareholder at 2.12%. There are no pledged promoter holdings or mutual funds invested in the company.

The top shareholders of Transpek Industries include the promoters, who hold the majority of the shares. The promoter with the highest holding is Anshul Specialty Molecules Private Limited, which owns 24.64% of the company. Additionally, individual investors collectively hold 31.39% of the shares. In terms of public shareholders, Mukul Mahavir Agrawal is the highest with a holding of 2.12%. There are also three foreign institutional investors (FIIs) that hold a small percentage of 0.03%. Notably, there are no pledged promoter holdings and no mutual funds currently invested in the company.

Has Transpek Inds. declared dividend?

Transpek Industry Ltd has declared a 140% dividend, amounting to ₹14 per share, with an ex-date of September 13, 2024. While the company shows mixed total returns over various periods, it has experienced negative returns in the short term and positive trends in the longer term.

Transpek Industry Ltd has declared a 140% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 140%<BR>- Amount per share: 14<BR>- Ex-date: 13 Sep 24<BR><BR>Dividend Yield: 0.87%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -1.75%, the dividend return was 0%, resulting in a total return of -1.75%.<BR><BR>Over the past year, the price return was -5.14%, the dividend return was 0.78%, leading to a total return of -4.36%.<BR><BR>In the last 2 years, the price return was -18.2%, the dividend return was 1.94%, which resulted in a total return of -16.26%.<BR><BR>For the 3-year period, the price return was 0.89%, the dividend return was 4.46%, culminating in a total return of 5.35%.<BR><BR>In the 4-year span, the price return was 8.12%, the dividend return was 4.36%, producing a total return of 12.48%.<BR><BR>Over the last 5 years, the price return was -7.51%, the dividend return was 4.76%, resulting in a total return of -2.75%.<BR><BR>Overall, Transpek Industry Ltd has declared a substantial dividend, but the total returns over various periods show a mixed performance, with negative returns in the shorter terms and a positive trend in the longer terms.